Avalon GloboCare (ALBT) Cash & Equivalents (2016 - 2026)
Avalon GloboCare filings provide 12 years of Cash & Equivalents readings, the most recent being $294001.0 for Q1 2026.
- On a quarterly basis, Cash & Equivalents fell 72.59% to $294001.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $294001.0, a 72.59% decrease, with the full-year FY2025 number at $109091.0, down 95.9% from a year prior.
- Cash & Equivalents hit $294001.0 in Q1 2026 for Avalon GloboCare, up from $109091.0 in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $3.9 million in Q3 2022 to a low of $76491.0 in Q4 2023.
- Median Cash & Equivalents over the past 5 years was $526290.0 (2022), compared with a mean of $929022.8.
- Biggest five-year swings in Cash & Equivalents: tumbled 96.16% in 2023 and later soared 3375.16% in 2024.
- Avalon GloboCare's Cash & Equivalents stood at $2.0 million in 2022, then tumbled by 96.16% to $76491.0 in 2023, then soared by 3375.16% to $2.7 million in 2024, then plummeted by 95.9% to $109091.0 in 2025, then skyrocketed by 169.5% to $294001.0 in 2026.
- The last three reported values for Cash & Equivalents were $294001.0 (Q1 2026), $109091.0 (Q4 2025), and $333931.0 (Q3 2025) per Business Quant data.